Table 4.
Wave 2 |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Onset of substance use |
|||||||||||||||||||
Never usea | Exclusive tobacco useb | Exclusive alcohol use | Exclusive marijuana usec | ||||||||||||||||
Wave 1 | ng | %h | SEh | ng | %h | SEh | ORi | 95% CIi | ng | %h | SEh | ORi | 95% CIi | ng | %h | SEh | ORi | ||
Total | 4090 | 77.0 | 0.7 | 246 | 4.4 | 0.3 | 422 | 8.2 | 0.4 | 53 | 0.9 | 0.1 | |||||||
Unadjusted model | |||||||||||||||||||
Susceptibility to tobacco usej | |||||||||||||||||||
No | 2956 | 81.9 | 0.8 | 113 | 3.0 | 0.3 | Referent | 255 | 7.3 | 0.5 | Referent | 29 | 0.7 | 0.1 | Referent | ||||
Yes | 1134 | 66.2 | 1.3 | 133 | 7.4 | 0.6 | 3.1 | 2.3 | 4.1 | 167 | 10.1 | 0.8 | 1.7 | 2.1 | 24 | 1.2 | 0.3 | 2.1 | |
Adjusted modelk | |||||||||||||||||||
Susceptibility to tobacco usej | |||||||||||||||||||
No | 2956 | 81.9 | 0.8 | 113 | 3.0 | 0.3 | Referent | 255 | 7.3 | 0.5 | Referent | 29 | 0.7 | 0.1 | Referent | ||||
Yes | 1134 | 66.2 | 1.3 | 133 | 7.4 | 0.6 | 2.4 | 1.7 | 3.3 | 167 | 10.1 | 0.8 | 1.5 | 1.8 | 24 | 1.2 | 0.3 | 1.6 |
Wave 2 |
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Onset of substance use |
||||||||||||||||||||
Exclusive marijuana usec |
Exclusive other drug used | Poly-substance including tobacco usee | Poly-substance excluding tobacco usef | |||||||||||||||||
Wave 1 | 95% CIi | ng | %h | SEh | ORi | 95% CIi | ng | %h | SEh | ORi | 95% CIi | ng | %h | SEh | ORi | 95% CIi | ||||
Total | 174 | 3.1 | 0.3 | 258 | 5.0 | 0.4 | 82 | 1.4 | 0.2 | |||||||||||
Unadjusted model | ||||||||||||||||||||
Susceptibility to tobacco usej | ||||||||||||||||||||
No | Referent | 131 | 3.5 | 0.3 | Referent | 89 | 2.5 | 0.3 | Referent | 43 | 1.2 | 0.2 | Referent | |||||||
Yes | 1.1 | 4.0 | 43 | 2.4 | 0.4 | 0.9 | 0.6 | 1.3 | 169 | 10.7 | 1.1 | 5.4 | 3.9 | 7.5 | 39 | 2.0 | 0.4 | 2.2 | 1.3 | 3.6 |
Adjusted modelk | ||||||||||||||||||||
Susceptibility to tobacco usej | ||||||||||||||||||||
No | Referent | 131 | 3.5 | 0.3 | Referent | 89 | 2.5 | 0.3 | Referent | 43 | 1.2 | 0.2 | Referent | |||||||
No | ||||||||||||||||||||
Yes | 0.8 | 3.1 | 43 | 2.4 | 0.4 | 0.8 | 0.5 | 1.2 | 169 | 10.7 | 1.1 | 3.9 | 2.8 | 5.6 | 39 | 2.0 | 0.4 | 1.8 | 1.1 | 3.0 |
Statistically significant associations at p < .05 indicated in bold text.
Reference group.
Refers to cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe, hookah, snus pouches, smokeless tobacco excluding snus pouches, or dissolvable tobacco.
Includes use of cigars as blunts.
Includes non-prescribed Ritalin/Adderall, non-prescribed painkillers/sedatives, cocaine and other stimulants, heroin, inhalants, solvents, and hallucinogens.
Includes use of two or more substances (tobacco, alcohol, marijuana, and other drugs).
Includes use of two or more substances (alcohol, marijuana, and other drugs).
n represents unweighted sample sizes.
Percents (%) and standard errors (SEs) represent weighted estimates.
Odds ratios (ORs) and 95% confidence intervals (CIs) from multinomial logistic regression models.
Defined as the strongest rejection to questions regarding curiosity about tobacco products, intention not to use tobacco products, and resistance of an offer to use tobacco products from a best friend.
Adjusted for age, sex, race/ethnicity, academic performance, sensation seeking, tobacco product user in household, receptivity to tobacco product advertising, and lifetime mental health problems at Wave 1.